Balloon Valvuloplasty Devices Market Size, Share & Trends Analysis Report By Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis), By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030
Balloon Valvuloplasty Devices Market Growth & Trends
The global balloon valvuloplasty devices market size is expected to reach USD 3.02 billion by 2030, registering a CAGR of 4.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases, including valvular heart diseases, new product launches, regulatory approvals, and advanced healthcare infrastructure, drives the demand for balloon valvuloplasty devices in North America. Rheumatic heart disease (RHD) is a serious cardiovascular condition that arises from damage to the heart valves due to rheumatic fever.
According to a report published by the American Heart Association in April 2024, valvular heart disease (VHD) is among the most prevalent health conditions in the U.S., affecting about 2.5% of the adult population. Aortic and mitral valve diseases are the most diagnosed types of VHD, further emphasizing the critical need for effective treatment options like balloon valvuloplasty devices to address this growing health concern.
Increasing awareness and screening programs fuel the market's growth. For instance, in September 2024, the Global Heart Hub initiated campaigns highlighting the rising prevalence of heart valve disease, which is expected to double by 2040 and triple by 2060. These efforts stress the critical role of early detection through regular medical check-ups. The organization aims to inform the public about the symptoms and available treatments, such as balloon valvuloplasty.
Balloon Valvuloplasty Devices Market Report Highlights
- Based on application, the aortic valve stenosis segment held the largest share, over 64%, in 2023. The global rise in the incidence of valvular heart diseases and technological advancements drive the segment's growth
- Based on end use, the hospital segment held the largest revenue share at 57.4% in 2023. The rising incidence of valvular heart diseases globally necessitates advanced solutions within hospitals to manage patient care effectively
- North America dominated the market with a share of 41.4% in 2023, owing to the rising cases of cardiovascular diseases, including valvular heart diseases. Product launches, regulatory approvals, and advanced healthcare infrastructure drive the demand for balloon valvuloplasty devices
- Market players operating in the balloon valvuloplasty devices market include B. Braun Interventional Systems, Inc., BD Interventional, Edwards Lifesciences, Boston Scientific Corporation, Getinge, Toray International America, Inc., Stryker, BrosMed Medical, Medtronic, Terumo Corporation, Philips
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. End-use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecast timeline.
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application Segment
- 2.2.2. End-use Segment
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
- Chapter 3. Global Balloon Valvuloplasty Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of valvular heart diseases
- 3.2.1.2. Technological advancements in balloon valvuloplasty devices
- 3.2.1.3. Increasing awareness and screening programs
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost associated with the devices and procedures
- 3.2.2.2. Regulatory compliance
- 3.3. Balloon Valvuloplasty Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Balloon Valvuloplasty Devices Market: Application Estimates & Trend Analysis
- 4.1. Balloon Valvuloplasty Devices Market: Application Dashboard
- 4.2. Balloon Valvuloplasty Devices Market: Application Movement Analysis
- 4.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 4.4. Aortic Valve Stenosis
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Pulmonary Valve Stenosis
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. Balloon Valvuloplasty Devices Market: End-use Estimates & Trend Analysis
- 5.1. Balloon Valvuloplasty Devices Market: End-use Dashboard
- 5.2. Balloon Valvuloplasty Devices Market: End-use Movement Analysis
- 5.3. Balloon Valvuloplasty Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Ambulatory Surgical Centers (ASCs)
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Cardiac Catheterization Labs
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. Balloon Valvuloplasty Devices Market: Regional Estimates & Trend Analysis by Country, Application, & End-use
- 6.1. Global Balloon Valvuloplasty Devices Market: Regional Dashboard
- 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 6.3. North America
- 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Canada
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4. Mexico
- 6.3.4.1. Key country dynamics
- 6.3.4.2. Regulatory framework/ reimbursement structure
- 6.3.4.3. Competitive scenario
- 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4. Europe
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. UK
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.3. Germany
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.4. France
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.5. Italy
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.6. Spain
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.8. Norway
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 6.4.9. Denmark
- 6.4.9.1. Key country dynamics
- 6.4.9.2. Regulatory framework/ reimbursement structure
- 6.4.9.3. Competitive scenario
- 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.3. Japan
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.4. India
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.5. Australia
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 6.5.7. South Korea
- 6.5.7.1. Key country dynamics
- 6.5.7.2. Regulatory framework/ reimbursement structure
- 6.5.7.3. Competitive scenario
- 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Regulatory framework/ reimbursement structure
- 6.6.3.3. Competitive scenario
- 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7. MEA
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.3. South Africa
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.4. UAE
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Regulatory framework/ reimbursement structure
- 6.7.5.3. Competitive scenario
- 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2023
- 7.3.4. B. Braun Interventional Systems, Inc.
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. BD Interventional
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Edwards Lifesciences
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Boston Scientific Corporation
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. Getinge
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Toray International America, Inc.
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Stryker
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
- 7.3.11. BrosMed Medical
- 7.3.11.1. Company overview
- 7.3.11.2. Financial performance
- 7.3.11.3. Product benchmarking
- 7.3.11.4. Strategic initiatives
- 7.3.12. Medtronic
- 7.3.12.1. Company overview
- 7.3.12.2. Financial performance
- 7.3.12.3. Product benchmarking
- 7.3.12.4. Strategic initiatives
- 7.3.13. Terumo Corporation
- 7.3.13.1. Company overview
- 7.3.13.2. Financial performance
- 7.3.13.3. Product benchmarking
- 7.3.13.4. Strategic initiatives
- 7.3.14. Philips
- 7.3.14.1. Company overview
- 7.3.14.2. Financial performance
- 7.3.14.3. Product benchmarking
- 7.3.14.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook